Cargando…

Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial

Detalles Bibliográficos
Autores principales: Koshak, Abdulrahman, Koshak, Emad A, Mobeireek, Abdullah F, Badawi, Mazen A, Wali, Siraj O, Malibary, Husam M, Atwah, Ali F, Alhamdan, Meshari M, Almalki, Reem A, Madani, Tariq A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier GmbH 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696021/
http://dx.doi.org/10.1016/j.eujim.2021.101899
_version_ 1784619712496271360
author Koshak, Abdulrahman
Koshak, Emad A
Mobeireek, Abdullah F
Badawi, Mazen A
Wali, Siraj O
Malibary, Husam M
Atwah, Ali F
Alhamdan, Meshari M
Almalki, Reem A
Madani, Tariq A
author_facet Koshak, Abdulrahman
Koshak, Emad A
Mobeireek, Abdullah F
Badawi, Mazen A
Wali, Siraj O
Malibary, Husam M
Atwah, Ali F
Alhamdan, Meshari M
Almalki, Reem A
Madani, Tariq A
author_sort Koshak, Abdulrahman
collection PubMed
description
format Online
Article
Text
id pubmed-8696021
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier GmbH
record_format MEDLINE/PubMed
spelling pubmed-86960212021-12-23 Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial Koshak, Abdulrahman Koshak, Emad A Mobeireek, Abdullah F Badawi, Mazen A Wali, Siraj O Malibary, Husam M Atwah, Ali F Alhamdan, Meshari M Almalki, Reem A Madani, Tariq A Eur J Integr Med Article Published by Elsevier GmbH 2021-12 2021-12-17 /pmc/articles/PMC8696021/ http://dx.doi.org/10.1016/j.eujim.2021.101899 Text en Copyright © 2021 Published by Elsevier GmbH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Koshak, Abdulrahman
Koshak, Emad A
Mobeireek, Abdullah F
Badawi, Mazen A
Wali, Siraj O
Malibary, Husam M
Atwah, Ali F
Alhamdan, Meshari M
Almalki, Reem A
Madani, Tariq A
Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
title Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
title_full Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
title_fullStr Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
title_full_unstemmed Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
title_short Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
title_sort nigella sativa supplementation accelerates recovery from mild covid-19: first randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696021/
http://dx.doi.org/10.1016/j.eujim.2021.101899
work_keys_str_mv AT koshakabdulrahman nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT koshakemada nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT mobeireekabdullahf nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT badawimazena nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT walisirajo nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT malibaryhusamm nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT atwahalif nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT alhamdanmesharim nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT almalkireema nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial
AT madanitariqa nigellasativasupplementationacceleratesrecoveryfrommildcovid19firstrandomizedcontrolledtrial